China has approved a drug for fighting with Alzheimer’s disease. This medicine is developed by the company from Shanghai, which is ready for the first time in itself. This medicine will be available for the common people from next month. In the last seventeen years, the first major research has been done in this field.
China’s National Medical Product Administration, in a statement, approved the introduction of this drug named ‘Oligomannet’ in the market. During the trial, this medicine started showing the effect on the patient within the first 4 weeks. This medicine has been developed nearly after two decades of hard work.